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ABSTRACT
Melioidosis is an emerging tropical infection
caused by the intracellular bacterium Burkholderia
pseudomallei, and is associated with high
mortality rates. Previous studies investigating
the prevalence of melioidosis have based conclu-
sions on serological evidence. However, cell-
mediated immunity is more relevant for protec-
tion against an intracellular pathogen such as B.
pseudomallei. This is the ﬁrst demonstration that
exposure to B. pseudomallei may lead to the
formation of speciﬁc antibodies and the devel-
opment of cell-mediated immunity in a healthy
individual.
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The incidence of melioidosis, seen predomin-
antly in Southeast Asia and northern Australia
[1], has increased over the past two decades
[2,3]. The causative bacterial agent, Burkholderia
pseudomallei, is distributed widely in soil and
water in endemic areas. There is a wide spec-
trum of clinical presentations resulting from
infection with B. pseudomallei. Acute septicaemic
melioidosis is the most severe form of the
disease, associated with mortality rates of 20–
70% [4–6]. Chronic asymptomatic infection can
persist for many years [3,6]. Disease may occur
in carriers as a consequence of haematological
malignancy or chemotherapy that erodes the
competence of the cellular immune system. This
parallels the clinical course of diseases such as
tuberculosis, where T-cells play a central role in
immune surveillance.
Little is known about protective immunity in
melioidosis. However, it has now been demon-
strated [7] that patients who recover from infec-
tion develop an adaptive cell-mediated immunity
(CMI). Although CMI is central for protection
against other intracellular infections, there is no
published evidence as to its importance in mel-
ioidosis. Understanding the role of CMI in mel-
ioidosis is essential for the development of
treatment and vaccination strategies. In this
study, antibody levels and cell-mediated immune
responses to B. pseudomallei were determined in a
group of healthy volunteers living in an endemic
area in northern Australia.
The 16 subjects enrolled in the study were of
non-indigenous origin. Eight subjects (all males;
age range 56–72 years) had served in Vietnam for
periods of 8–15 months, while the remaining
eight subjects (three females, ﬁve males; age
range 33–62 years) had never visited Vietnam.
None of the subjects had a history of melioidosis
or any other condition diagnosed as pyrexia of
unknown origin.
Peripheral blood mononuclear cells were sep-
arated from heparinised blood and cultured in
triplicate in 96-well plates (105 cells ⁄well). Cells
were stimulated with B. pseudomallei antigens [7]
1 lg ⁄mL, puriﬁed protein derivative (PPD; CSL
Biosciences, North Ryde, NSW, Australia)
15 lg ⁄mL, or the mitogen phytohaemagglutinin
(PHA; Sigma, Sydney, NSW, Australia)
10 lg ⁄mL. Cell proliferation was measured at
24-h intervals, and culture was followed for
4–7 days by measuring (3H)thymidine incorpor-
ation (Amersham Pharmacia Biotech, Sydney,
NSW, Australia; 1.25 lCi ⁄mL for 4 h). Results
were expressed as a stimulation index (SI = pro-
portion of counts ⁄min in stimulated cultures
compared to unstimulated cultures).
A semiquantitative indirect haemagglutination
assay was used to determine serum antibody
titres to B. pseudomallei antigens. Reaction titres
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>1:40 were considered to be positive for
B. pseudomallei [8,9].
The 16 subjects participating in the study were
stratiﬁed into two groups: those who served in
Vietnam (veterans; n = 8) and those who did not
(controls: n = 8). Maximal lymphocyte prolifer-
ation for each individual in both the veteran and
control groups was analysed using univariate
analysis of variance (SPSS software v. 11.5; SPSS
Inc., Chicago, IL, USA). Correlation between sets
of data was assessed by Pearson’s correlation
coefﬁcient and was considered signiﬁcant if the
probability of a type 1 error was < 0.05%
(p < 0.05).
There was a signiﬁcantly higher proliferation
of lymphocytes in response to B. pseudomallei
antigens in cells derived from veterans com-
pared with controls (p < 0.01; Fig. 1). Maximum
stimulation tended to occur between days 5 and
6 for both groups. High levels of proliferation
were observed in veterans (mean logn SI 4.50;
6.69) and controls (mean logn SI 6.60; 6.20) in
response to PPD and PHA stimulation, respect-
ively. However, there was no signiﬁcant differ-
ence in proliferation in response to stimulation
with either PPD or PHA between groups (p
> 0.05; Fig. 1).
All eight control sera were negative for B. pseu-
domallei antibodies (< 1:40). This pattern was
repeated in the veteran sera samples, apart from
one that showed a titre of 1:320. The small
number of subjects included in the study meant
that it was not possible to identify any correla-
tions between indirect haemagglutination titres
and cell-mediated immune responses. However,
the individual with a titre of 1:320 also demon-
strated a signiﬁcantly higher SI (logn SI 5.18) than
the control group (logn SI 0.83) and the veterans
group (logn SI 3.3). If the results for this
individual were removed from the statistical
analysis, the difference in maximum proliferative
capacity between veteran (logn SI 2.9) and
control groups (logn SI 0.83) remained signiﬁcant
(p < 0.05).
Epidemiological studies of B. pseudomallei
using serological assays have indicated that
sub-clinical infection is common, suggesting
frequent contact with the organism. In Vietnam,
seroconversion rates have varied between stud-
ies, ranging from 6% to 20% of residents tested.
In addition, c. 2% of healthy or non-wounded
army personnel showed signiﬁcant indirect
haemagglutination titres after spending 6–
12 months in Vietnam [10]. The Vietnam veter-
ans who took part in the current study comple-
ted a questionnaire indicating length of stay in
Vietnam, service capacity and primary region of
service. All veterans were situated in southern
provinces for periods of 8–15 months, and all
indicated extensive contact with soil and water
during this time. Australian studies have found
that Townsville has the highest seroconversion
rate (5.2%) for B. pseudomallei among urban
populations in northern Queensland [11]. How-
ever, the titres were disproportional between
different groups of people living in the same
region. Seropositive samples from people of
indigenous (7.9–10.6%) and Vietnamese (29%)
origin were 3–10-fold greater than for residents
of Caucasian origin.
In the present study, the only subject display-
ing serological evidence of exposure to B. pseu-
domallei also showed a signiﬁcant cellular
response to the organism. During intracellular
bacterial infection, antibodies are predominantly
Fig. 1. Proliferation of lymphocytes isolated from the
peripheral blood of Vietnam veterans and healthy control
subjects. The response to Burkholderia pseudomallei antigens
from veterans (n = 8; logn mean 3.30; logn range 0.32–5.18)
was more diverse than the response from control subjects
(n = 8; logn mean 0.83; logn range 0.13–1.26). One veteran
showed a signiﬁcantly higher SI than controls following
stimulation with B. pseudomallei antigens (logn SI 5.18) in
comparison with the control average (logn mean 0.83;
p < 0.01). In contrast, stimulation of lymphocytes with
both phytohaemagglutin (logn mean 6.69 vs. 6.20; p > 0.2)
and puriﬁed protein derivative (logn mean 4.50 vs. 4.28;
p > 0.2) produced similar values for veterans and control
subjects, respectively. Horizontal bars represent means.
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protective before the establishment of intracellu-
lar replication. Therefore, successful elimination
of the pathogen depends mainly on efﬁcient
interactions between antigen-speciﬁc T-cells and
infected macrophages [12]. Signiﬁcantly higher
cell proliferation and interferon-c production has
been shown in patients who had recovered from
melioidosis, and this was an indication of the
development of a speciﬁc cell-mediated immune
response to B. pseudomallei [7]. The current study
demonstrated that exposure to B. pseudomallei
may lead to the formation of speciﬁc antibodies
and the development of CMI in healthy individ-
uals. An adequate cell-mediated immune
response to B. pseudomallei may prevent the
development of disease. Based on these obser-
vations, a more comprehensive study is warran-
ted since there may be signiﬁcant implications
for individuals exposed to B. pseudomallei who
may require immunosuppression or chemother-
apy.
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ABSTRACT
Total lymphocyte counts, CD4 T-lymphocyte
counts and CD4 ⁄CD8 ratios were measured in 30
anti-retroviral-naive HIV-seropositive patients
upon hospital admission for acute community-
acquired pneumonia (CAP) caused by Streptococ-
cus pneumoniae, and again 1 month after resolution
of infection. There was a signiﬁcant depression of
the total lymphocyte count (p < 0.005) and CD4 T-
lymphocyte count (p < 0.001) in the acute stage of
CAP caused by S. pneumoniae, with a subsequent
increase in 90% (27 ⁄ 30) of cases after resolution of
the infection. There was no signiﬁcant difference
in the CD4 ⁄CD8 T-lymphocyte ratio on admission
compared with 1 month later (p 0.9).
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Signiﬁcant depression of total lymphocyte and
CD4 T-lymphocyte subset counts may occur in
Corresponding author and reprint requests: G. Schleicher,
Division of Pulmonology, Department of Medicine, Johannes-
burg Hospital and University of the Witwatersrand, Johan-
nesburg, South Africa
E-mail: Schleicher@worldonline.co.za
Research Note 587
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 574–592
